IGMS IGM Bio Total Asset Value of Company
This chart illustrates the total asset dynamics of IGM Biosciences, Inc. (IGMS), whose success relies on developing biologics for oncology centers and insurance companies. The company is implementing a unique platform for synthesizing IgM antibodies, which are ten times more effective than standard IgG in combating lymphomas. The current metric stands at 221.77, while the scaling of R&D projects is currently driving cost increases without generating profit.
Analytical breakdowns and data insights for company igmbio.com (IGMS)
- current quotes and average value forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio IGM Biosciences, Inc.|IGMS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio IGM Biosciences|IGMS - Company Aggregate Debts|Debts to Book Capitalization IGM Biosciences, Inc.|IGMS - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings IGM Biosciences|Interim Coverage Ratio igmbio.com
- net income and valuation multiples indicators:
Fundamental valuation:IGM Biosciences, Inc.
Steady demand for biomedical innovations at IGM Biosciences, Inc. (IGMS) renders the company a defensive asset, where analyzing total capital and liabilities via a reverse ROA calculation allows for an assessment of the actual scale of resources, including equity and debt, to timely identify the risk of declining asset utilization efficiency or missed opportunities to expand the business's fundamental value.
Key competitors
ARGX - Company Total Asset Base|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|Savara Corp - Company Total Assets|Company Total Asset Base Rigel Corp RIGL|ANAB: Company Total Assets|Company Balance Sheet Assets astriatx.com ATXS|Aggregate Company Assets enGene|Cumulative Company Assets RAPT Therapeutics Inc. (RAPT)|Cumulative Company Assets JBIO (Aerovate Therapeutics Inc)|ACRS (Aclaris Therapeutics, Inc) - Aggregate Asset Value|Company Total Assets KYTX (Kyverna Therapeutics)|tizianalifesciences.com - Aggregate Company Assets|Cabaletta Bio - Company Total Assets|Company Total Asset Base Ventyx Biosciences Inc. VTYX|Theratechnologies Inc (THTX) - Aggregate Company Assets|Company Assets Avalo Therapeutics Inc (AVTX)|Aggregate Company Assets Eledon Pharmaceuticals|agenusbio.com (AGEN) - Company Total Asset Base|Company Total Assets CLYM|Cumulative Company Assets Zura Bio Ltd ZURA|Company Total Assets ATYR (aTyr)|Company Total Asset Base Adagene Inc (ADAG)|Ikena Oncology, Inc. - Company Total Assets|Company Assets Shattuck Labs, Inc.|equilliumbio.com (EQ) - Aggregate Company Assets|Total Business Assets CNTB|IMUX (Immunic Therapeutics) - Company Total Assets|Cumulative Company Assets Atara Biotherapeutics Inc (ATRA)|Company Total Assets IFRX|XFOR - Company Assets|Aggregate Company Assets Adicet Bio, Inc. ACET|Company Total Asset Base Celularity Inc (CELU)|INMB: Cumulative Company Assets|Aggregate Asset Value BRNS (Barinthus Biotherapeutics Corp)|KZR: Company Total Assets|SABS - Company Total Asset Base|Aggregate Company Assets Akari Therapeutics Plc|Total Business Assets ENLV (Enlivex Therapeutics, Ltd.)|Company Total Assets QTTB|Cumulative Company Assets GeoVax Corp GOVX|Edesa Biotech, Inc. - Cumulative Company Assets|Company Total Asset Base ibioinc.com (IBIO)|Carisma Tx - Company Total Assets|Company Total Asset Base XTL Biopharmaceuticals Ltd XTLB|BOLT: Company Total Assets|Company Balance Sheet Assets HCW Biologics HCWB|Aggregate Company Assets Aptevo Therapeutics, Inc.|Cumulative Company Assets AIM ImmunoTech, Inc. (AIM)|Aggregate Company Assets Aditxt (ADTX)|Company Total Asset Base GRI Bio Inc|Aggregate Company Assets XORTX XRTX|HIND (Vyome Therapeutics) - Total Asset Value of Company|Revelation Biosciences - Company Total Assets|Aggregate Asset Value INDP (indaptusrx.com)|SCNI: Company Total Assets|CalciMedica (CALI) - Company Total Assets|Aggregate Company Assets Affimed NV|ALLK: Aggregate Asset Value|Aggregate Company Assets HOOKIPA Pharma Inc. (HOOK)|Cumulative Company Assets iteostherapeutics.com ITOS|Company Total Assets OCEA (Ocean Biomedical)|Company Total Assets TC BioPharm (Holdings) Plc TCBP|THRD: Cumulative Company Assets